Latest debt-to-equity ratio
Scribe Therapeutics Debt-to-equity ratio
Direct answer
Scribe Therapeutics's debt-to-equity ratio is 4.11%.
The verified market snapshot reports 4.11%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked November 19, 2026.
Get free Scribe Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 4.11%
Explore related company data
View Scribe Therapeutics's market capitalizationView Scribe Therapeutics's price-to-book ratioView Scribe Therapeutics's dividend yieldView Scribe Therapeutics's 52-week price rangeView Scribe Therapeutics's revenue growthView Scribe Therapeutics's profit marginView all Scribe Therapeutics key metricsReturn to Scribe Therapeutics profile